Wang, H.; Liu, J.; Lai, X.; Li, X.; Huang, W.
The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty. J. Clin. Med. 2023, 12, 1161.
https://doi.org/10.3390/jcm12031161
AMA Style
Wang H, Liu J, Lai X, Li X, Huang W.
The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty. Journal of Clinical Medicine. 2023; 12(3):1161.
https://doi.org/10.3390/jcm12031161
Chicago/Turabian Style
Wang, Han, Jiacheng Liu, Xiaofei Lai, Xinyu Li, and Wei Huang.
2023. "The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty" Journal of Clinical Medicine 12, no. 3: 1161.
https://doi.org/10.3390/jcm12031161
APA Style
Wang, H., Liu, J., Lai, X., Li, X., & Huang, W.
(2023). The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty. Journal of Clinical Medicine, 12(3), 1161.
https://doi.org/10.3390/jcm12031161